Samrat retweeted
Sadly, the Swedish pioneer of tobacco harm reduction with snus, Dr. Lars Ramström, has passed away at the age of 95.
Rest in peace, Mr. Ramström.
gfn.events/michael-russell/a…
Samrat retweeted
Smoking in UK has halved since 2011, with a slight uptick in vaping among never-smokers. @oommen from @orfonline calls that a Faustian bargain. We disagree.
India doesn’t have to choose between protecting teens and saving adult smokers. Our response 👇
vapeindia.org/analysis/not-a…
Samrat retweeted
You can’t tax people out of smoking,you can push them into the black market. Excessive taxation fuels this illicit trade, not public health. We need smarter taxes, tougher enforcement and access to safer nicotine alternatives ..
Nearly half of cigarettes sold in Kenya are illegal zurl.co/ypwzl
Samrat retweeted
We organised, thought our govt will see giving smokers access to vaping will save millions of lives. It protected cigarettes instead. Here we still are, fighting our govt for the right of 270mn Indians to choose safer alternatives.
#XAnniversary #RegulateNotBan – at Mumbai, India
Samrat retweeted
Why does gutka feature so little in a tobacco-control debate that spends so much time targeting vapes and nicotine pouches?
In his guest post, @zaruk challenges the movement’s priorities — and asks who is being left behind.
clearingtheair.eu/en/post/gu…
Samrat retweeted
Our detailed rebuttal to Prof Srinath Reddy article in @NewIndianXpress which inflates nicotine risks and proposes bans on safer alternatives.
@thePHFI @mohfw_India @icmr_nicpr @scroll_in @aiims_newdelhi @Hriday_Org @DghsIndia @imaIndiaorg @NITIAayog
vapeindia.org/analysis/nicot…
Samrat retweeted
Sky News has a short video following yesterday's article by Boidin et al in JAMA Cardiology.
Here's a clip from it featuring Dr. Matthew Evison, a Professor of Respiratory Medicine and one of the authors.
Samrat retweeted
Scientists are calling out this new study that compares 17 vapers to 19 smokers over 1 week while ignoring past smoking or exercise habits. Small exploratory studies shouldn't be used to scare smokers away from switching. @mohfw_India @icmr_nicpr @ANI
sciencemediacentre.org/exper…
📝 Editorial: Evidence on #ECigarettes indicates that vaping is associated with respiratory and vascular harm, while high-nicotine products, flavors, and marketing can rapidly establish #Nicotine addiction, especially among youth.
ja.ma/4i19RUw
Very sad news — ⬇️⬇️⬇️
SFATA is ceasing operations.
sfata.org/content.aspx?page_…
Samrat retweeted
Grandfather of New Zealand tobacco control and pioneer of e-cigarette research Dr Murray Laugesen (1935–2026)
It is with great sadness that I share the news of the death of Dr Murray Laugesen on 11 October 2026, aged 90. He was a public health physician whose work shaped tobacco control in NZ for more than 40 years.
Murray served as principal medical officer in the New Zealand Ministry of Health (1984–1995) and was central to the development of the world-leading Smoke-free Environments Act 1990. He received the WHO Tobacco or Health medal in 1998 and the Queen’s Service Order in 2000. After leaving the public service he continued independent research and advocacy through Health New Zealand and as the founder of End Smoking NZ (established 2006).
He was a relentless reader of the scientific literature and an example of open-minded inquiry—always looking for cracks in settled assumptions and for interventions that could reach people on the lowest incomes and in remote settings, not only those who could access cessation medicines or expensive devices. Under his leadership, End Smoking NZ first advocated for legal access to Swedish snus. When that path was denied, Murray turned immediately to the next promising development.
Murray conducted the first independent analysis of the first Ruyan e-cigarette developed by Chinese pharmacist Hon Lik. His chemical and toxicological assessments, followed by a randomised crossover trial (Bullen et al., Tobacco Control, 2010, which included Murray, me - Marewa Glover, and Hayden McRobbie, among the authors), were among the first independent evaluations of the product’s emissions, nicotine delivery, craving relief and acceptability. The device contained no tobacco and produced no smoke. Murray recognised its potential as a scalable harm-reduction tool.
With founding End Smoking NZ colleague Dr Ross McCormick (psychiatrist), he argued for regulated access on the same pragmatic grounds that support methadone programmes: not everyone can or will quit entirely, but a satisfying, affordable, alternative can reduce disease and death. From the late 2000s our group educated clinicians, policymakers and the public about vaping and pressed for sensible regulation. Murray understood that political and public acceptance of scientific advances can take decades but he stayed focused and persistent.
New Zealand eventually enabled adult access. Daily smoking prevalence roughly halved between the early 2010s and the mid-2020s, with the steepest declines coinciding with wider vaping uptake. Murray lived to see this outcome—an uncommon privilege for a researcher. Many long-term smokers have gained years of improved health; youth smoking has fallen to historic lows. As Sweden’s longer experience with lower-risk nicotine products has shown, reductions in lung cancer and cardiovascular disease are predicted to follow.
On a personal note, in 1993, Murray recruited me into this mission — to reduce the suffering and premature deaths caused by smoking-related disease. I count myself extremely fortunate to have worked with and be mentored by him. He modelled what it means to be a careful scientist: to read widely, hunt for promising ideas, and remain open to evidence that points to better approaches.
His passing is a loss to the international tobacco harm-reduction community. The practical, evidence-driven approach he championed continues to save lives.
Photo: Murray, Me & ex-ASH NZ Director Trish Fraser at launch of his 2019 memoir, ‘My Life in Public Health’.
Samrat retweeted
In India, toxic tobacco is getting cheaper compared to almost everything else, while the least harmful alternatives are banned. This is not tobacco control.
Samrat retweeted
Misinformed editorial by @businessline oblivious to the reality that India has 200M users of toxic oral tobacco, who will benefit greatly by switching to far safer nicotine pouches. Snuffing out safer alternatives is snuffing out lives.
thehindubusinessline.com/opi…
Samrat retweeted
India’s banned vape market hit $2.3B in 2025 and is still growing, almost as fast as the legal global market. The ban just handed the trade to a black market with no age checks and no tax. Our view...
@PMOIndia @JPNadda @NITIAayog @EACtoPM @ThePrintIndia
vapeindia.org/analysis/vape-…
Samrat retweeted
We've rebuilt our site.
New: court cases AVI fought since 2017, section for policymakers, living library of THR research, guide to what PECA actually bans (which does NOT include using a vape), and a way to report police harassment.
Have a look. Also..
vapeindia.org – at Mumbai, India
Samrat retweeted
shorturl.at/Airo9
I cover major trends in tobacco and tobacco harm reduction use, science, and policy. Value connects. Thanks to @MedSynapse
Samrat retweeted
US govt-funded study of 2013-2023 federal health data finds switch away from cigarettes to vaping will cut future cancer rates. India, with its huge tobacco health burden, should follow suit.
@PMOIndia @mohfw_India @icmr_nicpr @IMAIndiaOrg @NITIAayog
drugs.com/news/vaping-likely…
Samrat retweeted
I'm trying to crowdsource folks for a public statement. So... some help please!



















